# Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer

> **NCT00004876** · PHASE2 · COMPLETED · sponsor: **Cancer Research UK** · enrollment: 30 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** thalidomide

## Key facts

- **NCT ID:** NCT00004876
- **Lead sponsor:** Cancer Research UK
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-08
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004876, "Carboplatin With or Without Thalidomide in Treating Patients With Ovarian Epithelial Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00004876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*